Carregant...
Genotyping of cutaneous melanoma
Until recently, treatment options for patients with metastatic melanoma were very limited. This landscape has evolved dramatically since the discovery of activating mutations in the BRAF gene in ~45% of cutaneous melanomas. Vemurafenib, dabrafenib, and trametinib have all received regulatory approva...
Guardat en:
| Publicat a: | Chin Clin Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4306428/ https://ncbi.nlm.nih.gov/pubmed/25632386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2304-3865.2014.03.01 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|